Faculty of Health and Wellbeing, Sheffield Hallam University, Sheffield, UK.
Institute for Social Marketing and UK Centre for Tobacco and Alcohol Studies, University of Stirling, Stirling, UK.
Eur Urol. 2017 Jun;71(6):915-923. doi: 10.1016/j.eururo.2016.12.022. Epub 2017 Jan 7.
Use of electronic cigarettes (ECs) is on the rise in most high-income countries. Smoking conventional cigarettes is a known risk factor for urologic malignancy incidence, progression, and mortality, as well as for other urologic health indicators. The potential impact of EC use on urologic health is therefore of clinical interest to the urology community.
To review the available data on current EC use, including potential benefits in urologic patients, potential issues linked to toxicology of EC constituents, and how this might translate into urologic health risks.
A Medline search was carried out in August 2016 for studies reporting urologic health outcomes and EC use. Snowballing techniques were also used to identify relevant studies from recent systematic reviews. A narrative synthesis of data around EC health outcomes, toxicology, and potential use in smoking cessation and health policy was carried out.
We found no studies to date that have been specifically designed to prospectively assess urologic health risks, even in an observational setting. Generating such data would be an important contribution to the debate on the role of ECs in public health and clinical practice. There is evidence from a recent Cochrane review of RCTs that ECs can support smoking cessation. There are emerging data indicating that potentially harmful components of ECs such as tobacco-specific nitrosamines, polyaromatic hydrocarbons, and heavy metals could be linked to possible urologic health risks.
ECs might be a useful tool to encourage cessation of conventional cigarette smoking. However, data collection around the specific impact of ECs on urologic health is needed to clarify the possible patient benefits, outcomes, and adverse events.
While electronic cigarettes might help some people to stop smoking, their overall impact on urologic health is not clear.
在大多数高收入国家,电子烟的使用呈上升趋势。吸烟是泌尿系统恶性肿瘤发病、进展和死亡的已知危险因素,也是其他泌尿系统健康指标的危险因素。因此,电子烟的使用对泌尿系统健康的潜在影响引起了泌尿科医生的关注。
综述目前电子烟使用的相关数据,包括电子烟对泌尿系统患者的潜在益处、电子烟成分毒理学相关的潜在问题,以及这可能如何转化为泌尿系统健康风险。
2016 年 8 月,我们对报道泌尿系统健康结果和电子烟使用情况的研究进行了 Medline 检索。还使用滚雪球技术从最近的系统评价中确定相关研究。对电子烟健康结果、毒理学以及在戒烟和卫生政策方面的潜在应用的数据进行了叙述性综合。
我们目前尚未发现有专门设计的研究前瞻性评估电子烟使用的泌尿系统健康风险,即使是在观察性研究中。生成此类数据将是对电子烟在公共卫生和临床实践中作用的辩论的重要贡献。最近一项关于 RCT 的 Cochrane 综述的证据表明,电子烟可帮助戒烟。有新数据表明,电子烟中的潜在有害成分,如烟草特异性亚硝胺、多环芳烃和重金属,可能与可能的泌尿系统健康风险有关。
电子烟可能是鼓励停止使用传统香烟的有用工具。但是,需要收集有关电子烟对泌尿系统健康的具体影响的数据,以明确可能的患者受益、结果和不良事件。
虽然电子烟可能有助于一些人戒烟,但它们对泌尿系统健康的总体影响尚不清楚。